MHC class II-restricted antigen processing and presentation.
about
Polarized expression of CD74 by gastric epithelial cells.Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses.Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control studyDeficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHCAlternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese PopulationInhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.Diversity in MHC class II antigen presentation.Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDSIdentification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cellsCurrent advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cellsDown-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes.Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes).Influence of saccharide size on the cellular immune response to glycopeptides.Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis.Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.From Phagocytes to Immune Defense: Roles for Coronin Proteins in Dictyostelium and Mammalian Immunity.
P2860
Q30414247-125F0CC9-0B3B-41C2-BBD0-032199C1D233Q33264116-770BE7F9-FB05-4CA6-A31C-E3B871383327Q33849973-526637BA-8365-4D26-8D69-F07EFE210E1DQ34014518-81934830-6FBA-46B9-8E10-9385FE8797D2Q34082315-FCD8D6DE-25C8-494E-9CE2-8A5276CA2278Q34161849-C7586358-3A06-4FC4-9F88-05218EE4B719Q34190153-2D144E0B-5564-4FF1-A3EC-7E617B7617A5Q34309646-0CDCD01E-115C-4A00-A7E3-E8927CED0D17Q34330648-36F27C3B-6592-4811-A042-5B5DB85C645AQ34348786-2E280F3D-41AB-47E5-975A-AD95C448D340Q34349848-A86CA61F-A3D9-4504-95EA-0FC2EEDB3D40Q34579769-D6EFBAE8-F387-4610-BEBD-B8071C7CA29EQ34944392-8F950D14-FF31-4CC9-AE52-994280E2B2D0Q35139240-91C471AD-0CFA-4C0D-8473-0D27D9E5A917Q35214196-02AF467C-FC69-411D-837B-0D3DDE3D8770Q35637379-D0D03E2F-B521-41FE-9222-B6CE7B0E18FAQ35648247-DEB207EA-F2B0-4E14-8A49-EE7BD09F4251Q35803399-563D591B-34AD-4793-9C68-D9625831E63DQ36194606-68A574D4-9288-4A0F-8F85-0A6F3FC51D21Q36371928-C58765C7-BC54-4A5B-A9B4-47A272529251Q36524357-187D227A-6D25-4EF7-B397-18AD6C40E789Q37376557-CA5202C8-5E7F-40A6-86BB-E4462A7D50BAQ38213316-0E0A7AD4-FA19-46BC-B645-AC283F873B48Q39646925-1E619F92-0B3E-4A1A-B0CE-B8003866F416Q40737770-0BD40268-898C-4194-8CE3-2CBF87EB92DCQ44242427-610D12DB-B23E-4F98-9C3E-71B66FAE5067Q44566873-D9BE50A7-77B0-4AA6-8BA1-6456932500D8Q44619427-792162B6-C9CF-4451-80F1-0BA2A6E7DAA0Q50962872-F166B087-6828-4744-ACB0-9A1FC3042002Q55035064-4B97A53B-F691-46B8-83A1-F4ABF7646AEC
P2860
MHC class II-restricted antigen processing and presentation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
MHC class II-restricted antigen processing and presentation.
@ast
MHC class II-restricted antigen processing and presentation.
@en
type
label
MHC class II-restricted antigen processing and presentation.
@ast
MHC class II-restricted antigen processing and presentation.
@en
prefLabel
MHC class II-restricted antigen processing and presentation.
@ast
MHC class II-restricted antigen processing and presentation.
@en
P1476
MHC class II-restricted antigen processing and presentation.
@en
P2093
P304
P356
10.1016/S0065-2776(00)75004-8
P577
2000-01-01T00:00:00Z